HLA-DRB1–factor VIII Binding Is a Risk Factor for Inhibitor Development in Nonsevere Hemophilia: A Case-Control Study

Blood advances - United States
doi 10.1182/bloodadvances.2018019323
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

American Society of Hematology

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy